FDA Approval Demonstrates the Role of Real-World Evidence in Regulatory Decision-Making on Drug Effectiveness
Ozlem Belen, MD, MPH, Deputy Director of the Division of Rheumatology and Transplant Medicine, Office of New Drugs John Concato, MD, MPH, MS, Associate Director of Real-World Evidence Analytics, Office of Medical Policy Stefanie Kraus, JD, MPH, Senior …